Table 1.
Demographic of DTC patients
| Characteristics | N (%) | |
|---|---|---|
| Age (years) | ||
| Mean ± SD | 49.9 ± 14.3 | |
| Gender | ||
| Female | 133 (83.1) | |
| Male | 27 (16.9) | |
| Follow-up duration (years) | ||
| Median (interquartile range) | 4.0 (2.0–7.0) | |
| Histology | ||
| Papillary | 135 (84.4) | |
| Follicular | 17 (10.6) | |
| Mixed | 7 (4.4) | |
| Hürthle cell | 1 (0.6) | |
| TgAb status during thyroid hormone therapy | ||
| Positive TgAb (≥40 IU/mL) | 27 (16.9) | |
| Negative TgAb (<40 IU/mL) | 133 (83.1) | |
| Clinical status at the follow-up | ||
| No evidence of disease (NED) | 49 (30.6) | |
| Thyroid remnants | 14 (8.8) | |
| Biochemical persistent disease | 28 (17.5) | |
| Structural persistent disease | 69 (43.1) |